Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells
Seiichi Okabe(Tokyo Medical University), Kazuma Ohyashiki(Tokyo Medical University)
Cited by 21
Related Papers
Effect of the extracellular component of bone marrow mesenchymal stromal cells from healthy donors on hematologic neoplasms and their angiogenesis
|Human Cell|2020|11